Webinar Date/Time: Tue, Mar 5, 2024 2:00 PM EST
The sponsor, commercial, scientific, and program management teams each play a crucial role in the tech transfer process. Hear real-world tips from each of these stakeholders in this webinar.
Your clinical biomanufacturing program can be derailed if you don't pay attention to tech transfer details. Sponsors and CDMOs are eager to get contracts signed, but often overlook the crucial steps in the tech transfer process that will set the program up for success.
The sponsor, commercial, scientific, and program management teams each play a crucial role in the process. Hear from each of these stakeholders and gain insight based on real-world examples from recent tech transfers for early-stage clinical programs.
This webinar will cover:
Key Learning Objectives:
Who Should Attend:
VP, Process Sciences
Brian O'Mara, Scorpius' VP of Process Sciences, has 20-plus years of experience in downstream process development of early- and late-stage protein therapeutics from mammalian and microbial expression systems. He also has extensive experience the development of protein conjugates, including ADCs, bi-specifics, and PEGylated molecules. He has experience in scale-up and technology transfer, CDMO management, process characterization, preparation and oversight of PPQ campaigns, and associated CMC regulatory filings.
Director, Business Development
Kris Morton has more than 10 years of experience in process engineering and commercial operations. His background in process automation and optimization, tech transfer, equipment and process validation, and financial modeling make him an asset to sponsors with clinical manufacturing programs. Kris holds a BS in Chemical Engineering and Biochemistry & Molecular Biology from Rose-Hulman Institute of Technology, and both an MS (Finance) and an MBA from Indiana University’s Kelley School of Business
Sr. Marketing Manager
Abby Sorensen joined Scorpius BioManufacturing after spending nine years in media. Her experience includes business development, content creation, trade show planning and execution, and project management. She has consulted on biopharma marketing strategies for Fortune 500 companies as well as startups. In her role at Scorpius, she also assists clients with their marketing strategy to help elevate their awareness to the investor and partnering community.